These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11312452)

  • 21. Longterm methotrexate therapy in rheumatoid arthritis: a review.
    Kremer JM
    J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():25-8. PubMed ID: 3913773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methotrexate.
    Boffa MJ
    Adv Exp Med Biol; 1999; 455():341-2. PubMed ID: 10599367
    [No Abstract]   [Full Text] [Related]  

  • 23. Liver biopsy in methotrexate-treated psoriatics-a re-evalution.
    Zachariae H; Grunnet E; Sogaard H
    Acta Derm Venereol; 1975; 55(4):291-6. PubMed ID: 52258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver biopsy in psoriasis.
    Berge G; Lundquist A; Rorsman H; Akerman M
    Br J Dermatol; 1970 Mar; 82(3):250-3. PubMed ID: 5441759
    [No Abstract]   [Full Text] [Related]  

  • 25. Hepatotoxicity of long-term methotrexate therapy for psoriasis.
    Tobias H; Auerbach R
    Arch Intern Med; 1973 Sep; 132(3):391-6. PubMed ID: 4783020
    [No Abstract]   [Full Text] [Related]  

  • 26. Monitoring liver function during methotrexate therapy for psoriasis: are routine biopsies really necessary?
    Thomas JA; Aithal GP
    Am J Clin Dermatol; 2005; 6(6):357-63. PubMed ID: 16343024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methotrexate-related nonnecrotizing multifocal axonopathy detected by beta-amyloid precursor protein immunohistochemistry.
    Vega RS
    Arch Pathol Lab Med; 2002 Sep; 126(9):1017; author reply 1017. PubMed ID: 12240624
    [No Abstract]   [Full Text] [Related]  

  • 28. Liver injury associated with methotrexate therapy for psoriasis.
    Podurgiel BJ; McGill DB; Ludwig J; Taylor WF; Muller SA
    Mayo Clin Proc; 1973 Nov; 48(11):787-92. PubMed ID: 4758150
    [No Abstract]   [Full Text] [Related]  

  • 29. The use of antipyrine clearance to measure liver damage in psoriatic patients receiving methotrexate.
    Paramsothy J; Strange R; Sharif H; Collins M; Shaw P; Lawrence CM
    Br J Dermatol; 1988 Dec; 119(6):761-5. PubMed ID: 3203069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Revised guidelines on methotrexate use and liver biopsy.
    Borislow DS; Davis I
    Am J Gastroenterol; 1989 Jul; 84(7):841. PubMed ID: 2741901
    [No Abstract]   [Full Text] [Related]  

  • 31. The aminopyrine breath test, an inadequate early indicator of methotrexate-induced liver disease in patients with psoriasis.
    Williams CN; McCauley D; Malatjalian DA; Turnbull GK; Ross JB
    Clin Invest Med; 1987 Mar; 10(2):54-8. PubMed ID: 3581546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guidelines for routine liver biopsy during methotrexate treatment.
    Cash JM; Wilke WS
    Cleve Clin J Med; 1994; 61(4):317-8. PubMed ID: 7923752
    [No Abstract]   [Full Text] [Related]  

  • 33. Liver Illness and Psoriatic Patients.
    Fiore M; Leone S; Maraolo AE; Berti E; Damiani G
    Biomed Res Int; 2018; 2018():3140983. PubMed ID: 29546055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe liver damage caused by treatment of psoriasis with methotrexate.
    Pai SH; Werthamer S; Zak FG
    N Y State J Med; 1973 Nov; 73(21):2585-7. PubMed ID: 4518596
    [No Abstract]   [Full Text] [Related]  

  • 35. Acute kidney injury, agranulocytosis, drug-induced liver injury, and posterior reversible encephalopathy syndrome caused by high-dose methotrexate-possible role of low activity ABC and SLC drug transporters.
    Bielen L; Kralj I; Ćurčić E; Vodanović M; Boban A; Božina N
    Eur J Clin Pharmacol; 2018 Sep; 74(9):1191-1192. PubMed ID: 29789870
    [No Abstract]   [Full Text] [Related]  

  • 36. Daily practice assessment of liver injury in patients with psoriasis on methotrexate.
    Driessen RJ; van de Kerkhof PC; de Jong EM
    Br J Dermatol; 2010 Jan; 162(1):211-3. PubMed ID: 19903179
    [No Abstract]   [Full Text] [Related]  

  • 37. Focal skin toxicity related to methotrexate sparing psoriatic plaques.
    Truchuelo T; Alcántara J; Moreno C; Vano-Galván S; Jaén P
    Dermatol Online J; 2010 Jun; 16(6):16. PubMed ID: 20579471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Incidence of liver diseases in psoriatic patients with special reference to methotrexate therapy].
    Moldenhauer E; Dabels J; Diwok K; Leithäuser W; Nowotny P
    Dermatol Monatsschr; 1973 Mar; 159(3):242-8. PubMed ID: 4704945
    [No Abstract]   [Full Text] [Related]  

  • 39. Methotrexate and psoriasis.
    JAMA; 1969 Sep; 209(12):1898. PubMed ID: 5820079
    [No Abstract]   [Full Text] [Related]  

  • 40. Psoriasis, methotrexate, and cirrhosis.
    JAMA; 1970 Apr; 212(2):314-5. PubMed ID: 5467236
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.